R&D at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Arrowhead Research in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arrowhead Research's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arrowhead Research's R&D?
- Arrowhead Research (ARWR) reported R&D of $173.25M in Q1 2026.
- How has Arrowhead Research's R&D changed year-over-year?
- Arrowhead Research's R&D increased by 30.2% year-over-year, from $133.1M to $173.25M.
- What is the long-term trend for Arrowhead Research's R&D?
- Over 4 years (2021 to 2025), Arrowhead Research's R&D has grown at a 31.0% compound annual growth rate (CAGR), from $206.34M to $607.16M.
- What does R&D mean?
- The money spent on creating new products and improving existing ones.
- How do you interpret R&D?
- Higher spending suggests an active pipeline and investment in future growth, whereas lower spending might indicate a shift toward commercialization or cost-cutting.
- How does R&D compare across companies?
- High relative to revenue for early-stage biotech; lower for mature pharmaceutical companies.